Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Evolus (EOLS) EBIT (2018 - 2025)

Evolus (EOLS) has disclosed EBIT for 8 consecutive years, with $4.2 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBIT rose 282.37% year-over-year to $4.2 million, compared with a TTM value of -$32.7 million through Dec 2025, up 5.08%, and an annual FY2025 reading of -$32.7 million, up 5.08% over the prior year.
  • EBIT was $4.2 million for Q4 2025 at Evolus, up from -$11.5 million in the prior quarter.
  • Across five years, EBIT topped out at $8.0 million in Q1 2021 and bottomed at -$21.3 million in Q2 2022.
  • Average EBIT over 5 years is -$11.3 million, with a median of -$12.7 million recorded in 2023.
  • The sharpest move saw EBIT plummeted 292.47% in 2022, then soared 282.37% in 2025.
  • Year by year, EBIT stood at -$18.0 million in 2021, then skyrocketed by 40.97% to -$10.6 million in 2022, then increased by 18.82% to -$8.6 million in 2023, then surged by 73.2% to -$2.3 million in 2024, then skyrocketed by 282.37% to $4.2 million in 2025.
  • Business Quant data shows EBIT for EOLS at $4.2 million in Q4 2025, -$11.5 million in Q3 2025, and -$10.2 million in Q2 2025.